دورية أكاديمية

A Genomic Perspective on the Near-term Impact of Doxycycline Post-exposure Prophylaxis on Neisseria gonorrhoeae Antimicrobial Resistance.

التفاصيل البيبلوغرافية
العنوان: A Genomic Perspective on the Near-term Impact of Doxycycline Post-exposure Prophylaxis on Neisseria gonorrhoeae Antimicrobial Resistance.
المؤلفون: Mortimer TD; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA., Grad YH; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
المصدر: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2023 Sep 11; Vol. 77 (5), pp. 788-791.
نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
اللغة: English
بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE
أسماء مطبوعة: Publication: Jan. 2011- : Oxford : Oxford University Press
Original Publication: Chicago, IL : The University of Chicago Press, c1992-
مواضيع طبية MeSH: Neisseria gonorrhoeae*/genetics , Gonorrhea*/epidemiology , Gonorrhea*/prevention & control , Gonorrhea*/drug therapy, Humans ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Doxycycline/pharmacology ; Doxycycline/therapeutic use ; Post-Exposure Prophylaxis ; Microbial Sensitivity Tests ; Drug Resistance, Bacterial/genetics ; Genomics ; Tetracycline/pharmacology
مستخلص: Pre-existing tetracycline resistance in Neisseria gonorrhoeae limits the effectiveness of post-exposure prophylaxis (PEP) with doxycycline against gonorrhea, and selection for tetracycline resistance may influence prevalence of multi-drug resistant strains. Using genomic and antimicrobial susceptibility data from N. gonorrhoeae, we assessed the near-term impact of doxycycline PEP on N. gonorrhoeae resistance.
Competing Interests: Potential conflicts of interest. Y. H. G. has received consulting fees from GSK and serves on the advisory board for Day Zero Diagnostics. Y. H. G. also reports grants or contracts from Wellcome Trust and Smith Family Foundation. T. D. M. reports no potential conflicts. Both authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
(© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
التعليقات: Update of: medRxiv. 2023 Mar 17;:. (PMID: 36993406)
References: J Infect Dis. 2018 Jul 24;218(5):801-808. (PMID: 29701830)
Euro Surveill. 2022 Nov;27(46):. (PMID: 36398578)
MMWR Morb Mortal Wkly Rep. 2020 Dec 18;69(50):1911-1916. (PMID: 33332296)
Sex Transm Dis. 2015 Feb;42(2):98-103. (PMID: 25585069)
Sex Transm Dis. 2023 Aug 1;50(8):490-493. (PMID: 36952471)
Ann N Y Acad Sci. 2019 Jan;1435(1):93-109. (PMID: 29876934)
Lancet Infect Dis. 2016 Nov;16(11):1295-1303. (PMID: 27427203)
Lancet Microbe. 2022 May;3(5):e376-e381. (PMID: 35544098)
J Comput Biol. 2012 May;19(5):455-77. (PMID: 22506599)
Nat Commun. 2019 Sep 5;10(1):3988. (PMID: 31488838)
Sex Transm Infect. 2022 May;98(3):235-236. (PMID: 35414633)
Int J STD AIDS. 1995 Sep-Oct;6(5):345-7. (PMID: 8547415)
Euro Surveill. 2023 Mar;28(10):. (PMID: 36892469)
Antimicrob Agents Chemother. 1995 Aug;39(8):1864-5. (PMID: 7486935)
Lancet Infect Dis. 2018 Mar;18(3):308-317. (PMID: 29229440)
Antimicrob Agents Chemother. 2016 Jun 20;60(7):4339-41. (PMID: 27067334)
J Infect Dis. 1973 Apr;127(4):461-6. (PMID: 4632883)
Sex Transm Dis. 2021 Aug 1;48(8S):S78-S87. (PMID: 33993166)
N Engl J Med. 2023 Apr 6;388(14):1296-1306. (PMID: 37018493)
Clin Infect Dis. 2020 Mar 3;70(6):1247-1253. (PMID: 31504345)
PLoS One. 2014 Nov 19;9(11):e112963. (PMID: 25409509)
Nucleic Acids Res. 2015 Feb 18;43(3):e15. (PMID: 25414349)
Sex Transm Dis. 2023 May 1;50(5):317-319. (PMID: 36728331)
معلومات مُعتمدة: R01 AI132606 United States AI NIAID NIH HHS; R01 AI153521 United States AI NIAID NIH HHS
المشرفين على المادة: 0 (Anti-Bacterial Agents)
N12000U13O (Doxycycline)
F8VB5M810T (Tetracycline)
تواريخ الأحداث: Date Created: 20230504 Date Completed: 20230913 Latest Revision: 20240505
رمز التحديث: 20240505
مُعرف محوري في PubMed: PMC10495131
DOI: 10.1093/cid/ciad279
PMID: 37138444
قاعدة البيانات: MEDLINE
الوصف
تدمد:1537-6591
DOI:10.1093/cid/ciad279